

Provider of antigen-specific immunotherapy. The company offers antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases.
Anokion was founded in 2012 and its current CEO is John Hohneker. Since its inception 14 years ago, Anokion has grown to 12 employees.
| Headquarter | EPFL Innovation Park-L, Ecublens 1024 Switzerland |
|---|---|
| Website | www.anokion.com |
| Founding Date | 2012 |
| Company Status | Private |

John Hohneker CEO / President
John Hohneker serves as the CEO / President of Anokion.

Deb Geraghty Chief Business Officer
Deb Geraghty serves as the Chief Business Officer of Anokion. Deb started at Anokion in April of 2018. Deb is currently...

Anthony Rossomando VP Technical Operations
Anthony Rossomando serves as the VP Technical Operations of Anokion. Anthony started at Anokion in March of 2018....

Stephan Kontos Chief Scientific Officer
Stephan Kontos serves as the Chief Scientific Officer of Anokion. Stephan started at Anokion in March of 2018. Stephan...
Leading members of the Anokion Human Resources Team include Betsy Kassler.

Betsy Kassler Human Resources Director
Betsy Kassler serves as the Human Resources Director of Anokion. Betsy started at Anokion in September of 2017. Betsy...

No Recent Jobs found for Anokion on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Anokion address?
Anokion location is at EPFL Innovation Park-L, Ecublens
How many employees work in Anokion?
Anokion has 12 employees
Who is Anokion leadership?
Deb Geraghty, Anthony Rossomando & Stephan Kontos are part of Anokion leadership, John Hohneker is the CEO